Macular Degeneration (AMD)
Age-related macular degeneration (AMD) is a progressive retinal disease that affects the macula, the central area of the retina responsible for detailed vision, reading, and recognizing faces.
What Is Macular Degeneration?
Age-related macular degeneration (AMD) is a chronic disease affecting the macula, the specialized central region of the retina responsible for sharp, detailed vision.
The macula allows important visual tasks such as reading, driving, recognizing faces, and seeing fine details. When the macula becomes damaged, central vision may become blurred, distorted, or reduced.
AMD does not usually cause complete blindness because peripheral vision is often preserved. However, advanced disease can significantly affect independence and quality of life.
Normal Macula vs Macular Degeneration
The macula requires a healthy relationship between photoreceptors, retinal pigment epithelium, Bruch’s membrane, and the choroidal blood supply.
Normal Macula
A healthy macula provides clear central vision through organized retinal cells and normal metabolic function.
- Healthy photoreceptors
- Normal retinal pigment epithelium
- Stable oxygen supply
- Clear central vision
Macular Degeneration
AMD causes progressive damage to macular structures, affecting central visual function.
- Drusen formation
- Retinal pigment changes
- Photoreceptor damage
- Central vision impairment
Why Does Macular Degeneration Occur?
AMD develops through complex interactions between aging, genetics, inflammation, and changes in the retinal support system.
Retinal Aging
With aging, cellular waste products accumulate beneath the retina, affecting normal retinal function.
Drusen Formation
Small deposits called drusen accumulate between the retinal pigment epithelium and Bruch’s membrane.
Abnormal Blood Vessel Growth
In wet AMD, abnormal blood vessels develop beneath the retina and may leak fluid or blood.
Macular Anatomy & Function
The macula contains specialized retinal structures responsible for high-acuity vision.
Macula
The central retinal region responsible for detailed vision, reading, and facial recognition.
Fovea
The central area of the macula containing the highest concentration of cone photoreceptors.
Retinal Pigment Epithelium
A supportive retinal layer responsible for photoreceptor maintenance and waste removal.
Choroid
A vascular layer supplying oxygen and nutrients to the outer retina.
Types and Clinical Forms of Macular Degeneration
Early AMD
The earliest stage characterized by small to medium drusen and minimal retinal changes.
Intermediate AMD
Larger drusen and pigmentary changes increase the risk of progression to advanced disease.
Advanced AMD
Severe macular damage resulting in significant central vision impairment.
Dry AMD (Non-Exudative)
The most common form involving gradual degeneration of retinal tissues and possible geographic atrophy.
Wet AMD (Neovascular)
A more aggressive form caused by abnormal blood vessel growth beneath the retina leading to leakage and bleeding.
Symptoms & Clinical Signs
Macular degeneration primarily affects central vision. Early stages may produce minimal symptoms, but progression can cause difficulty with reading, driving, recognizing faces, and performing detailed visual tasks.
Common Symptoms
- Blurred central vision
- Difficulty reading small print
- Need for brighter lighting
- Difficulty recognizing faces
- Distorted or wavy vision
- Dark or blurry spots in central vision
- Reduced contrast sensitivity
- Difficulty adapting to dim lighting
Clinical Findings
- Drusen beneath the retina
- Retinal pigmentary changes
- Geographic atrophy
- Macular thinning
- Subretinal fluid
- Retinal hemorrhage
- Choroidal neovascularization
- Macular scarring
Amsler Grid Changes in AMD
The Amsler grid is a simple home monitoring tool used to detect changes in central vision that may suggest progression of macular disease.
Normal Vision
Straight lines appear continuous and evenly spaced without distortion or missing areas.
Possible AMD Changes
Patients may notice wavy lines, missing areas, blurred sections, or dark spots when viewing the grid.
Risk Factors & Causes
Macular degeneration develops through a combination of aging-related changes, genetic susceptibility, and environmental factors affecting retinal health.
Age-Related Factors
- Increasing age
- Age greater than 50 years
- Accumulation of retinal cellular damage
- Reduced retinal repair ability
Genetic Factors
- Family history of AMD
- Inherited susceptibility
- Complement pathway gene variations
- Higher risk among first-degree relatives
Smoking and Macular Degeneration
Smoking is one of the strongest modifiable risk factors associated with the development and progression of AMD.
Effects on Retina
Smoking increases oxidative stress, inflammation, and vascular damage affecting macular health.
Disease Progression
Smokers have increased risk of developing advanced AMD, particularly the neovascular form.
Cardiovascular and Lifestyle Risk Factors
Hypertension
High blood pressure may contribute to vascular changes that affect retinal circulation.
High Cholesterol
Abnormal lipid levels may contribute to deposits and inflammation within retinal structures.
Obesity
Metabolic inflammation associated with obesity may increase AMD risk.
Physical Inactivity
Reduced physical activity is associated with increased cardiovascular and retinal health risks.
Nutrition and Macular Health
Diet plays an important role in maintaining retinal health and may influence the risk of AMD progression.
Protective Nutrients
- Lutein
- Zeaxanthin
- Omega-3 fatty acids
- Antioxidants
- Leafy green vegetables
Dietary Considerations
- Maintain balanced nutrition
- Reduce excessive saturated fats
- Control cardiovascular risk factors
- Discuss supplements when appropriate
Environmental Factors
Environmental exposures may contribute to oxidative stress and retinal aging.
Ultraviolet Exposure
Long-term light exposure may contribute to retinal oxidative stress, making sun protection important.
Oxidative Stress
Free radical damage may contribute to retinal pigment epithelial dysfunction.
How Does Macular Degeneration Progress?
AMD develops gradually as damage accumulates within the macula and retinal support structures.
Dry AMD Progression
- Drusen accumulation
- Retinal pigment changes
- Photoreceptor loss
- Geographic atrophy development
Wet AMD Progression
- Abnormal blood vessel growth
- Leakage beneath retina
- Subretinal hemorrhage
- Rapid central vision decline
Diagnosis of Macular Degeneration
A comprehensive retinal evaluation is necessary to identify AMD, determine severity, and monitor progression.
Clinical Examination
- Dilated fundus examination
- Macular evaluation
- Retinal pigment assessment
- Detection of drusen
Imaging Evaluation
- OCT macula
- Fundus photography
- Fluorescein angiography
- OCT angiography
Macular Degeneration Diagnostic Testing
Optical Coherence Tomography (OCT)
Provides detailed cross-sectional images of retinal layers and detects fluid, atrophy, and structural changes.
Fundus Photography
Documents retinal appearance, drusen, pigment changes, and progression over time.
Fluorescein Angiography
Uses injected dye to identify abnormal blood vessels and leakage associated with wet AMD.
OCT Angiography
Provides noninvasive visualization of retinal and choroidal blood flow patterns.
Amsler Grid Testing
Helps patients monitor central vision changes between eye examinations.
Visual Acuity Testing
Measures the effect of macular disease on functional vision.
AMD Classification
| Stage | Clinical Features |
|---|---|
| Early AMD | Small drusen and minimal retinal changes |
| Intermediate AMD | Large drusen and pigment abnormalities |
| Advanced Dry AMD | Geographic atrophy with retinal tissue loss |
| Wet AMD | Choroidal neovascularization with leakage or bleeding |
Differential Diagnosis
Diabetic Macular Edema
Retinal swelling caused by diabetes that can resemble macular thickening.
Retinal Vein Occlusion
Blocked retinal blood vessels may cause hemorrhage and macular edema.
Macular Hole
A structural defect in the macula causing central vision distortion.
Epiretinal Membrane
A thin scar-like tissue layer on the retina that can distort central vision.
Treatment Options for Macular Degeneration
Treatment for macular degeneration depends on the type and stage of disease. The goals are to slow progression, preserve remaining vision, prevent severe vision loss, and improve quality of life.
Lifestyle Modification
Healthy lifestyle choices can reduce risk factors associated with AMD progression and support long-term retinal health.
Observation & Monitoring
Early and intermediate AMD may be monitored regularly with retinal examinations, OCT imaging, and home vision monitoring.
Nutritional Therapy
Specific vitamin and mineral combinations may reduce progression risk in selected patients with intermediate AMD.
Retinal Injection Therapy
Wet AMD is commonly treated with medications injected into the eye to block abnormal blood vessel growth.
Lifestyle & Risk Reduction
Although AMD cannot always be prevented, modifying risk factors can help protect macular health and reduce progression risk.
Healthy Habits
- Stop smoking
- Maintain regular physical activity
- Control blood pressure
- Maintain healthy cholesterol levels
- Schedule routine eye examinations
Protecting the Retina
- Wear sunglasses with UV protection
- Maintain a balanced diet
- Monitor vision changes
- Use Amsler grid when recommended
AREDS2 Nutritional Supplement Therapy
The Age-Related Eye Disease Study 2 (AREDS2) formulation may reduce the risk of progression from intermediate AMD to advanced AMD in certain patients.
Lutein & Zeaxanthin
Macular pigments that help filter damaging blue light and support retinal function.
Vitamin C & Vitamin E
Antioxidants that help reduce oxidative stress affecting retinal cells.
Zinc
Supports retinal metabolism and normal function of the retinal pigment epithelium.
Copper
Included in AREDS2 formulations to reduce the risk of copper deficiency from zinc supplementation.
AREDS2 supplements are not a cure for AMD and are not recommended for everyone. Patients should discuss supplementation with their eye care provider.
Observation & Monitoring
Many patients with early AMD do not require treatment but should receive regular monitoring to detect progression.
Early AMD Monitoring
Routine examinations help track drusen development and retinal changes.
Intermediate AMD Monitoring
Closer follow-up may be recommended because of increased risk of advanced AMD.
Home Monitoring
Patients may monitor for distortion or missing areas using an Amsler grid.
Anti-VEGF Therapy for Wet AMD
Wet AMD occurs when abnormal blood vessels grow beneath the retina, causing leakage, bleeding, and rapid central vision changes. Anti-VEGF medications block vascular endothelial growth factor (VEGF), reducing abnormal vessel activity.
Aflibercept
An anti-VEGF medication commonly used to treat neovascular AMD by reducing fluid leakage and abnormal vessel growth.
Ranibizumab
A targeted anti-VEGF medication that improves retinal fluid control and helps preserve central vision.
Bevacizumab
An anti-VEGF medication frequently used off-label because of effectiveness and cost considerations.
Faricimab
A newer medication targeting VEGF and angiopoietin pathways to help control retinal vascular leakage.
Intravitreal Injection Treatment
Anti-VEGF medications are delivered directly into the vitreous cavity through an intravitreal injection performed under sterile conditions.
Treatment Goals
- Reduce retinal fluid
- Control abnormal blood vessels
- Prevent further vision loss
- Preserve central vision
Follow-Up Care
- Regular OCT monitoring
- Assessment of retinal fluid
- Repeat injections when necessary
- Long-term retinal follow-up
Photodynamic Therapy (PDT)
Photodynamic therapy uses a light-activated medication to selectively target abnormal blood vessels beneath the retina.
Verteporfin
A photosensitive medication activated by laser light to damage abnormal choroidal blood vessels.
Current Role
Used less frequently today but may be considered for selected retinal vascular conditions.
Laser Treatment for Macular Degeneration
Laser treatment historically played a role in managing certain forms of wet AMD. Modern anti-VEGF therapy has replaced laser for many patients.
Thermal Laser Photocoagulation
Uses heat energy to destroy selected abnormal blood vessels outside the central macula.
Limitations
Laser may damage surrounding retinal tissue and is not suitable for all cases.
Low Vision Rehabilitation
Patients with advanced AMD may benefit from low vision services designed to maximize remaining vision and improve independence.
Magnification Devices
Special optical devices can improve reading and near tasks.
Electronic Aids
Digital magnifiers and accessibility technology can enhance visual function.
Environmental Adaptation
Improved lighting, contrast enhancement, and organization can increase safety.
Wet AMD Management Approach
Wet AMD requires prompt treatment because abnormal blood vessel growth can cause rapid and permanent central vision loss.
Diagnosis
- OCT imaging
- Retinal examination
- Angiographic evaluation when needed
Treatment
- Anti-VEGF injections
- Regular OCT monitoring
- Long-term retinal care
Macular Degeneration Treatment Comparison
| Treatment | Purpose | Common Use |
|---|---|---|
| AREDS2 Supplements | Reduce progression risk | Intermediate AMD |
| Anti-VEGF Injection | Reduce abnormal vessel leakage | Wet AMD |
| Photodynamic Therapy | Target abnormal vessels | Selected cases |
| Low Vision Rehabilitation | Improve daily function | Advanced AMD |
Complications of Macular Degeneration
Advanced macular degeneration can lead to significant central vision loss due to damage involving the macula, retinal pigment epithelium, and underlying choroidal structures.
Dry AMD Complications
- Geographic atrophy
- Progressive photoreceptor loss
- Retinal pigment epithelial damage
- Difficulty reading and recognizing faces
- Permanent central vision reduction
Wet AMD Complications
- Choroidal neovascularization
- Subretinal fluid accumulation
- Retinal hemorrhage
- Macular scarring
- Rapid central vision loss
Geographic Atrophy
Geographic atrophy is an advanced form of dry AMD characterized by progressive loss of retinal pigment epithelium, photoreceptors, and supporting retinal structures.
Cause
Progressive cellular damage and retinal aging lead to degeneration of the macular tissue responsible for central vision.
Symptoms
Patients may experience gradual difficulty reading, reduced contrast, and missing areas in central vision.
Management
Monitoring, lifestyle modification, low vision support, and emerging therapies may help preserve function.
Choroidal Neovascularization (CNV)
Choroidal neovascularization occurs when abnormal blood vessels grow from the choroid beneath the retina. These vessels may leak fluid or blood, causing wet AMD.
Clinical Features
- Sudden distortion of vision
- New central blurry spot
- Loss of visual detail
- Subretinal fluid
- Retinal hemorrhage
Management
- Anti-VEGF injections
- OCT monitoring
- Long-term retinal follow-up
- Additional therapy when needed
Subretinal Hemorrhage
Subretinal hemorrhage occurs when abnormal blood vessels associated with wet AMD bleed beneath the retina, potentially causing sudden and severe vision changes.
Symptoms
Patients may notice sudden blurred vision, distortion, dark spots, or rapid decrease in central vision.
Cause
Fragile abnormal blood vessels created by choroidal neovascularization can leak or rupture.
Treatment
Management may include anti-VEGF therapy and specialized retinal intervention depending on severity.
Macular Degeneration and Central Vision Loss
AMD primarily affects central vision while usually preserving peripheral vision. The severity of vision loss depends on the location and extent of macular damage.
Early Disease
Patients may have minimal symptoms despite retinal changes detectable during eye examination.
Moderate Disease
Reading, facial recognition, and detailed tasks may become increasingly difficult.
Advanced Disease
Severe macular damage can result in significant loss of central visual function.
Prognosis
The prognosis of macular degeneration depends on the type of AMD, stage of disease, treatment response, and individual risk factors.
Although AMD can cause permanent central vision changes, early detection, appropriate monitoring, and modern treatments can help preserve vision and maintain quality of life.
Dry AMD
Often progresses slowly. Regular monitoring helps detect progression to advanced disease.
Wet AMD
Requires prompt treatment because untreated abnormal blood vessel growth may cause rapid and permanent vision loss.
Clinical Pearls
- AMD affects central vision but usually does not cause complete blindness.
- Smoking is one of the strongest modifiable risk factors for AMD progression.
- New distortion on an Amsler grid requires prompt retinal evaluation.
- Wet AMD can progress rapidly and requires urgent treatment.
- OCT imaging is essential for detecting retinal fluid and monitoring treatment.
- AREDS2 supplements may benefit selected patients with intermediate AMD.
- Family history increases risk and should be discussed during eye examinations.
- Low vision rehabilitation can significantly improve independence in advanced AMD.
Common ICD-10 Codes
| Code | Description |
|---|---|
| H35.31 | Nonexudative age-related macular degeneration |
| H35.311 | Nonexudative AMD, right eye |
| H35.312 | Nonexudative AMD, left eye |
| H35.313 | Nonexudative AMD, bilateral |
| H35.32 | Exudative age-related macular degeneration |
| H35.323 | Exudative AMD, bilateral |
Living With Macular Degeneration: Patient Tips
Monitor Vision Changes
Report new distortion, blurry spots, or sudden changes in vision promptly.
Protect Retinal Health
Avoid smoking, maintain a healthy diet, and control cardiovascular risk factors.
Attend Eye Exams
Regular retinal examinations allow early detection and treatment of progression.
Use Visual Aids
Low vision devices and rehabilitation can improve daily activities and independence.
Frequently Asked Questions
What causes macular degeneration?
AMD develops from a combination of aging-related retinal changes, genetic factors, and environmental influences.
Does macular degeneration cause blindness?
AMD usually affects central vision rather than peripheral vision. Complete blindness is uncommon, but advanced disease can significantly impair daily activities.
Can dry AMD become wet AMD?
Yes. Some patients with dry AMD can develop abnormal blood vessel growth, leading to wet AMD.
Can AMD be cured?
There is currently no complete cure, but monitoring and treatment can slow progression and preserve vision.
What are symptoms of wet AMD?
Common warning signs include sudden distortion, blurry central vision, dark spots, or rapid vision changes.
How often should AMD patients have eye exams?
Follow-up frequency depends on disease severity and treatment needs. Patients with advanced or active disease often require closer monitoring.
Related Eye Conditions
Diabetic Retinopathy
A diabetes-related retinal vascular disease that can also affect the macula.
Retinal Vein Occlusion
A retinal vascular blockage that may cause hemorrhage and macular swelling.
Macular Hole
A structural opening in the macula causing central vision distortion.
Epiretinal Membrane
A thin membrane forming over the retina that may distort central vision.
Medical Disclaimer
The information provided by Kardia Vision is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
If you experience sudden vision changes, distortion, new floaters, flashes of light, or decreased central vision, seek evaluation from a licensed eye care professional.
Kardia Vision is dedicated to improving eye health awareness by providing accurate, evidence-based educational resources for patients, students, and healthcare professionals.